NEW YORK STATE COMMON RETIREMENT FUND - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,686
+32.9%
33,331
+22.7%
0.00%0.0%
Q2 2023$1,269
+19.8%
27,172
-1.8%
0.00%
+100.0%
Q1 2023$1,059
-40.8%
27,682
-15.2%
0.00%
-50.0%
Q4 2022$1,788
-99.7%
32,629
+61.2%
0.00%
+100.0%
Q3 2022$689,000
+300.6%
20,237
+11.3%
0.00%
Q2 2022$172,000
-33.6%
18,182
-0.2%
0.00%
Q1 2022$259,000
-32.7%
18,222
+0.1%
0.00%
Q4 2021$385,000
-5.6%
18,197
-0.4%
0.00%
Q3 2021$408,000
-25.5%
18,266
-17.4%
0.00%
-100.0%
Q2 2021$548,000
+40.9%
22,104
+65.0%
0.00%
Q1 2021$389,000
+12.4%
13,4000.0%0.00%
Q4 2020$346,000
+11.3%
13,400
+32.7%
0.00%
Q3 2020$311,000
+23.4%
10,1000.0%0.00%
Q2 2020$252,000
+125.0%
10,100
+90.6%
0.00%
Q1 2020$112,000
-5.1%
5,3000.0%0.00%
Q4 2019$118,000
-2.5%
5,3000.0%0.00%
Q3 2019$121,0005,3000.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders